No NFO data available for this page.
3 Year return
0Investment Details
Calculate Returns
Based on past performance of this fund
Risk Involved
Tax Implications
Fund Holdings
Other Holdings | % of Asset |
---|---|
Zydus Lifesci. | 5.03 % |
Divi's Lab. | 4.7 % |
Fortis Health. | 4.2 % |
Apollo Hospitals | 3.92 % |
Alkem Lab | 3.8 % |
Medi Assist Ser. | 2.39 % |
FDC | 2.39 % |
Ajanta Pharma | 2.37 % |
Health.Global | 2.32 % |
Ipca Labs. | 2.14 % |
Orchid Pharma | 2.11 % |
Torrent Pharma. | 2.1 % |
Net CA & Others | 1.8 % |
Sanofi India | 1.79 % |
Jupiter Life Lin | 1.47 % |
Wockhardt | 1.23 % |
Mankind Pharma | 1.1 % |
Aster DM Health. | 1.03 % |
Indoco Remedies | 1.01 % |
Piramal Pharma | 0.96 % |
Medplus Health | 0.93 % |
P & G Health Ltd | 0.88 % |
Syngene Intl. | 0.83 % |
Coromandel Inter | 0.81 % |
Ami Organics | 0.69 % |
Glaxosmi. Pharma | 0.57 % |
Reverse Repo | 0.49 % |
Deepak Nitrite | 0.49 % |
NA
Fund House Details
Peer Comparison
Comparison with other similar funds
Funds
|
3 Y Returns
|
ARQ Rating
|
---|---|---|
Invesco India PSU Equity Fund Direct Plan IDCW (Payout / Payout) |
42.14% |
0 |
Quant Infrastructure Fund IDCW Direct Plan Payout |
38.55% |
0 |
Invesco India Infrastructure Fund Direct Plan IDCW (Payout / Payout) |
37.43% |
0 |
Schemes by Tata Mutual Fund
List of mutual fund schemes by AMC
Key Features of The Fund
5-year return | NA |
Expense Ratio | NA |
Fund Manager | NA |
Fund Size | NA |
Risk Profile | NA |
AMC Contact Details
Name | NA |
Launch Date | NA |
Addresss | NA |
Contact | NA |
NA | |
Website | NA |
Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.